Related Experiment Video
Updated: Mar 13, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
An Intensive Diabetes Screening and Treatment Program Improves Diagnosis, Treatment and Outcomes of Diabetes in
1Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Insights
An intensive diabetes screening and treatment program for cardiac patients significantly increased the diagnosis of diabetes mellitus (DM) and impaired glucose regulation (IGR). This approach also reduced hospital costs and length of stay for cardiac patients with abnormal glucose metabolism.
Area of Science:
- Cardiology
- Endocrinology
- Healthcare Management
Background:
- Patients with cardiac diseases, particularly ischemic heart disease, exhibit a high prevalence of diabetes mellitus (DM).
- Inadequate glucose control poses a significant risk for cardiac patients, necessitating targeted screening and management strategies.
- Existing care may not adequately identify or manage diabetes in this vulnerable population.
Purpose of the Study:
- To evaluate the effectiveness of an intensive diabetes screening and treatment program in hospitalized cardiac patients.
- To assess the program's impact on the diagnosis rates of DM and impaired glucose regulation (IGR).
- To determine the program's influence on hospitalization costs and length of stay.
Main Methods:
- A prospective study involving adult inpatients in two cardiac wards (Ward-A and Ward-B) at Nanjing Hospital, China.
- Ward-A received an intensive screening and treatment program for DM/IGR alongside routine care.
- Ward-B received only routine examination and treatment; outcomes were compared between wards.
Main Results:
- The intensive program in Ward-A identified a higher prevalence of DM (29.7%) and IGR (7.8%) compared to Ward-B (17.85% DM).
- Overall abnormal glucose metabolism was detected in 37.5% of Ward-A patients.
- Ward-A patients experienced significantly reduced medical costs and shorter hospital stays, particularly those undergoing percutaneous coronary intervention (PCI).
Conclusions:
- The intensive screening and treatment program effectively increases the diagnosis rate of DM and IGR in cardiac inpatients.
- This program leads to better hyperglycemia control, shorter hospitalizations, and lower medical and total costs.
- Implementing such programs is beneficial for managing comorbid diabetes in cardiovascular care settings.
Abstract:
Aim: Patients with cardiac diseases, especially ischemic heart disease, are known to have a high prevalence of diabetes mellitus (DM). They are at risk of having inadequate glucose control. An intensive diabetes screening and treatment program was developed to identify and treat DM in patients admitted with cardiac diseases. Methods: Adult inpatients of 2 cardiac wards, namely Ward-A and Ward-B, at Nanjing Hospital, Nanjing, China, were studied. Patients were randomly assigned into either ward. In addition to routine examination and treatment, an intensive screening and treatment program to identify and treat patients with DM or impaired glucose regulation (IGR) was only applied in Ward-A patients. The glycated serum protein concentration, the length of hospitalization, and medical and total hospital cost were compared between the 2 wards. Results: The prevalence of DM was 17.85% in Ward-B. With implementation of this program, DM was higher in Ward-A (29.7%) and the prevalence of IRG was 7.8%. The overall prevalence of abnormal glucose metabolism was 37.5% in Ward-A. This program is associated with significantly reduced medical cost and length of inhospital days in patients requiring percutaneous coronary intervention (PCI) and reduced both the medical and total hospital costs in patients without PCI of Ward-A as compared with those of Ward-B who received standard treatment. Conclusion: The intensive screening and treatment program increases diagnosis rate of DM and IRG in inpatient with cardiac diseases, more effectively controls hyperglycemia, and is associated with shorter length of inhospital days and lower medical and total hospital costs. The trial registry number: ChiCTR-IPR-15007487.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes: Symptoms, Diagnosis, and Complications
Cardiomyopathy V: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational

